⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL486394 | 1.00 | — | — | |
| SCHEMBL3884487 | 1.00 | — | — | |
| SCHEMBL15320712 | 0.83 | FOLH1 (0.36) | — | |
| SCHEMBL15320713 | 0.83 | FOLH1 (0.36) | — | |
| SCHEMBL19501717 | 0.80 | — | — | |
| SCHEMBL27529709 | 0.79 | — | — | |
| SCHEMBL4410363 | 0.79 | — | — | |
| SCHEMBL5088899 | 0.77 | CA2 (0.41) | — | |
| SCHEMBL8751952 | 0.77 | — | — | |
| SCHEMBL3669379 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2013234-A2 | PEPTIDE COMPOUND WITH BIOLOGICAL ACTIVITY, ITS PREPARATION AND ITS APPLICATION | Sanofi-aventis Spa (IT) | 2009-01-14 | — | — | EP | claimed |
| WO-2007113691-A2 | PEPTIDE COMPOUND WITH BIOLOGICAL ACTIVITY, ITS PREPARATION AND ITS APPLICATION | SANOFI-AVENTIS SPA (IT) | 2007-10-11 | — | — | WO | claimed |
| CN-112979509-B | Trifluoromethanesulfonyl alkynamide compound and preparation method and application thereof | 江西师范大学 | 2022-04-22 | — | — | CN | disclosed |
| EP-2013234-A2 | PEPTIDE COMPOUND WITH BIOLOGICAL ACTIVITY, ITS PREPARATION AND ITS APPLICATION | Sanofi-aventis Spa (IT) | 2009-01-14 | — | — | EP | disclosed |
| WO-2007113691-A2 | PEPTIDE COMPOUND WITH BIOLOGICAL ACTIVITY, ITS PREPARATION AND ITS APPLICATION | SANOFI-AVENTIS SPA (IT) | 2007-10-11 | — | — | WO | disclosed |
| US-6762280-B2 | CLOSTRIDIAL NEUROTOXIN SUBSTRATE FOR USE AS DIAGNOSTIC TOOL IN GENETIC ENGINEERING | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2004-07-13 | — | — | US | disclosed |